Clinical Trials on Primary Breast Cancer in United Kingdom
Total 42734 results
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLC; Cancer Research UK; Astex Pharmaceuticals, Inc.RecruitingCervical Cancer | Triple Negative Breast Cancer | Advanced CancerUnited Kingdom
-
Imperial College LondonMedical Research Council; ECMCRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerUnited Kingdom
-
AstraZenecaCompletedPostmenopausal Women With ER+ HER2- Primary Breast CancerGermany, United Kingdom
-
University of NottinghamUniversity of OxfordCompletedFamilial Breast CancerUnited Kingdom
-
Syantra Inc.Unknown
-
Cardiff UniversityWithdrawnMetastatic Breast CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomTerminatedMetastatic Breast CancerUnited Kingdom
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; National Institute for Health...Enrolling by invitationBreast Cancer FemaleUnited Kingdom
-
University of OxfordPublic Health England; Cancer Research UKActive, not recruitingBreast Cancer MortalityUnited Kingdom
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; Breakthrough Breast CancerUnknown
-
University of BathCompletedBreast Cancer FemaleUnited Kingdom
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonUnknown
-
University College, LondonNational Institute for Health Research, United KingdomCompletedBreast Cancer | Invasive Breast CancerUnited Kingdom
-
Ourotech, Inc.Barts & The London NHS Trust; Imperial College Healthcare NHS Trust; Hampshire... and other collaboratorsRecruitingBreast Cancer | Triple Negative Breast CancerUnited Kingdom
-
Queen Mary University of LondonHoffmann-La Roche; MedSIR; Westdeutsche Studiengruppe GmbH (WSG)Active, not recruitingTriple Negative Breast CancerUnited Kingdom
-
Queen Mary University of LondonAstellas Pharma IncUnknownPrimary Breast Cancer ER+ve | Primary Breast Cancer AR+ve TNBNGermany, United Kingdom, Spain, United States, Ireland
-
Queen Mary University of LondonHoffmann-La Roche; Asan Medical Center; Kliniken Essen-Mitte; MedSIRActive, not recruitingBreast Cancer | Estrogen Receptor-positive Breast CancerUnited Kingdom
-
University of OxfordCompletedBreast Cancer | Ovarian CancerUnited Kingdom
-
Norfolk and Norwich University Hospitals NHS Foundation...CompletedBreast Cancer Related LymphoedemaUnited Kingdom
-
University of East AngliaQuadram Institute Bioscience; Clinical Research and Trials Unit (Norfolk &... and other collaboratorsCompleted
-
AstraZenecaQuotient SciencesCompletedER-positive, HER2-negative Breast CancerUnited Kingdom
-
Royal Marsden NHS Foundation TrustCompletedMetastatic Breast CancerUnited Kingdom
-
Ourotech, Inc.Barts & The London NHS TrustRecruitingTriple Negative Breast Cancer | Triple Negative Breast NeoplasmsUnited Kingdom
-
King's College LondonGuy's and St Thomas' NHS Foundation Trust; Brighton and Sussex University Hospitals...Recruiting
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer (MBC) | Locally Advance Breast Cancer (LABC)United Kingdom, Spain
-
University College, LondonUnknownRadiotherapy | Breast Conserving Surgery | Women With Early Breast CancerUnited Kingdom
-
Scottish Cancer Therapy NetworkUnknown
-
Royal Marsden NHS Foundation TrustPfizer; Breast Cancer NowRecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Recurrent Breast Cancer | ER+ Breast CancerUnited Kingdom
-
Novartis PharmaceuticalsUniversity of Sheffield; Danish Breast Cancer Cooperative GroupCompletedHormone Sensitive Resected Primary Breast Cancer in Postmenopausal WomenDenmark, United Kingdom
-
Manchester University NHS Foundation TrustRecruitingBreast Cancer FemaleUnited Kingdom
-
National Health Service, United KingdomSouthern Health and Social Care TrustCompleted
-
University of ManchesterManchester University NHS Foundation TrustCompleted
-
Imperial College LondonCancer Research UKCompletedMetastatic Breast Cancer | Locally Advanced Breast CancerUnited Kingdom
-
PIQUR Therapeutics AGHospital Universitari Vall d'Hebron Research Institute; Institut Català d'Oncologia and other collaboratorsCompletedMetastatic Breast CancerSpain, United Kingdom
-
Zedsen LimitedImperial College Healthcare NHS TrustRecruitingBreast Cancer | Benign Breast DiseaseUnited Kingdom
-
Imperial College Healthcare NHS TrustImperial College LondonTerminatedBreast Cancer | Breast DiseaseUnited Kingdom
-
Imperial College LondonCompletedToxicity From Medication (Endocrine Treatment and Chemotherapy) Given for Breast Cancer Treatment.United Kingdom
-
University of OxfordoxBRC; Vodafone UK Foundation; Centre for Statistics in Medicine; Oncology Clinical...CompletedMetastatic Colorectal Cancer | Metastatic Breast CancerUnited Kingdom
-
Royal Marsden NHS Foundation TrustRecruitingBreast Cancer | LymphedemaUnited Kingdom
-
University of LeedsBreast Cancer NowCompletedMetastatic Breast CancerUnited Kingdom
-
PfizerCompletedBreast Cancer MetastaticArgentina, United Kingdom
-
University of AberdeenNHS GrampianUnknownMalignant Breast Tissue NeoplasmUnited Kingdom
-
King's College Hospital NHS TrustRecruitingBreast CancerUnited Kingdom
-
Lightpoint Medical LimitedNot yet recruiting
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompleted
-
Imperial College LondonTerminatedBreast CancerUnited Kingdom
-
University of StirlingOxford Brookes University; University of BathWithdrawn
-
Royal Marsden NHS Foundation TrustUnknownBreast CancerUnited Kingdom
-
AstraZenecaCompleted
-
Institute of Cancer Research, United KingdomGlaxoSmithKlineCompletedBreast CancerUnited Kingdom